Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-25-010109
Filing Date
2025-01-28
Accepted
2025-01-28 20:37:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3225
  Complete submission text file 0000950170-25-010109.txt   4775
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Subject) CIK: 0001422143 (see all company filings)

EIN.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37620 | Film No.: 25566331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KURA ONCOLOGY, INC. 12730 HIGH BLUFF DR SUITE 400 SAN DIEGO CA 92130
Business Address
Burrows Francis (Reporting) CIK: 0002051119 (see all company filings)

Type: 144